Seeking Alpha

Shares of microcap Alexza Pharmaceuticals (ALXA) soar 74% premarket on the strength of an...

Shares of microcap Alexza Pharmaceuticals (ALXA) soar 74% premarket on the strength of an approval from the Psychopharmacologic Drugs Advisory Committee of the FDA on its Adasuve drug for the treatment of schizophrenia or bipolar mania. The committee approved the drug by a narrow margin of 9 to 8 with 1 member abstaining.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs